Marketed By
bayer pharma
Pack of
60 tablet
Salt Composition
Sorafenib
Storage
Keep in cold place
Delivering To: —
All Substitutes
Overview
- Nexavar 200 mg is a cancer medicine that contains sorafenib, designed to help slow the growth and spread of certain advanced cancers. Doctors often prescribe it for liver cancer that can’t be removed surgically, advanced kidney cancer, and thyroid cancers that no longer respond to radioactive iodine treatment.
- It works by blocking signals that tumors use to grow and form new blood vessels.
- The usual dose is two tablets twice a day, taken on an empty stomach or with a light, low‑fat meal.
- The side effects of taking the Nexavar include fatigue, diarrhea, nausea, skin rash, hair loss, or skin changes on the hands and feet.
- It can lead to other complications, including hypertension, bleeding problems, and allergic skin reactions; constant supervision is required during the course of its usage.
Indication
- Liver Cancer (Hepatocellular Carcinoma)
- Kidney Cancer (Advanced Renal Cell Carcinoma)
- Thyroid Cancer (Differentiated Thyroid Carcinoma)
Uses
- Liver Cancer (Hepatocellular Carcinoma)
- Kidney Cancer (Advanced Renal Cell Carcinoma)
- Thyroid Cancer (Differentiated Thyroid Carcinoma)
Side Effects
Most side effects of Nexavar 200mg Tablets do not require medical attention, as they may disappear as your body adjusts to the medicine. In case these side effects become worse, consult your doctor immediately.
Common Side Effects
- Tiredness, weakness, or flu‑like symptoms
- Nausea, vomiting, stomach or abdominal pain, diarrhea
- Loss of appetite and weight loss
- Hair thinning or patchy hair loss
- Rash, skin problems, or dry/itchy skin
- Painful blisters on hands and feet (hand‑foot skin reaction)
- Headache or infection
- Low calcium levels in the blood
Serious Side Effects
- Severe skin reactions (Stevens‑Johnson Syndrome, toxic epidermal necrolysis)
- Decreased blood flow to the heart, heart problems
- High blood pressure
- Increased risk of bleeding (blood in urine, stool, vomit, or cough)
- Liver problems
- Delayed or impaired wound healing
Dosage and Administration
- Nexavar tablets 200 mg are usually administered twice daily or as directed by the physician. Nexavar should be taken intact along with a glass of water on an empty stomach, one hour before or two hours after food.
- In order to maximize the effects of this tablet, it is necessary that you strictly follow the instructions of the doctor and never change the dosage on your own.
- If you find that you are feeling fine even with the intake of the medication, continue with the treatment as per the doctor's instructions.
Mechanism of action
- Nexavar 200 mg acts on different kinases, which are enzymes that promote tumor growth and proliferation.
- This Nexavar tablet inhibits RAF kinases, which prevent cell replication, and VEGF receptors, which prevent the formation of blood vessels.
- In turn, by depriving the tumor of its nutrient supply, it helps reduce the nourishment of cancer cells.
- Furthermore, this medication disrupts the signals that regulate tumor development through inhibition of PDGFR and KIT.
- In general, Nexavar is a treatment approach that targets the cancer cells as well as their vessels.
Safety Advice
Alcohol
CONSULT YOUR DOCTOR
Pregnancy
UNSAFE
Breast Feeding
UNSAFE
Driving
DANGER
Kidney
PRECAUTION
Liver
PRECAUTION
Missed Doses
If you forget to take a dose of Nexavar 200mg Tablet, consult your doctor. Don’t double up the next dose to cope with the missed one unless your doctor recommends it.
FAQs
The Nexavar tablet is used to treat liver cancer, kidney cancer, and thyroid cancer.
Store the medicine below 30 degrees temperature in a dry place.
Pregnant women should consult with their doctor first before taking cancer medicines as they can harm the unborn baby.
Self-medication is strictly prohibited. You are not allowed to take it without consulting the doctor.
The doctor will decide the duration and dosage of the treatment. Self-medication is strictly prohibited. You are not allowed to take it without consulting the doctor.
References
- Arora, S. P., Moseley, J. L., Arellano, L. M., Salazar, M., Altermatt, B., Fuentes, L., Pham, V. T., Huang, G., Sun, L., Michalek, J., & Mahalingam, D. (2025, January 27). Phase II study of modulation of sorafenib‑induced autophagy using hydroxychloroquine in advanced hepatocellular cancer (HCC). Journal of Clinical Oncology, 43(4_suppl), 586. https://doi.org/10.1200/JCO.2025.43.4_suppl.586.
- Author(s) unspecified. (2023). Real-world effectiveness and tolerability of sorafenib in unresectable hepatocellular carcinoma: A U.S. multicenter retrospective cohort study. OncoDaily.
- Author(s) unspecified. (2024). Sorafenib plus hepatic arterial infusion chemotherapy vs sorafenib monotherapy in advanced hepatocellular carcinoma: A systematic review and meta-analysis. Journal of Clinical Medicine.
- Bayer HealthCare & Roche. (2024). Phase III randomized study of sorafenib plus erlotinib (SEARCH) versus sorafenib monotherapy in advanced hepatocellular carcinoma. Clinical Trial Protocol.
- Fan, G., & Wei, X. (2025). Immune checkpoint inhibitor combinations versus sorafenib as first-line therapy in hepatocellular carcinoma: Systematic review and meta-analysis of clinical trials. Therapeutic Advances in Medical Oncology, 17, 1–14.
Ratings And Reviews
4.60/5
5 Ratings
5 Star
80.00%
4 Star
0.00%
3 Star
20.00%
2 Star
0.00%
1 Star
0.00%
Nisha Kumar
Impressed with the quality
a year ago
Harper Hernandez
Decent product
a year ago
View All Reviews
Related Products
MARKETER DETAILS
bayer pharma
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.

